This study looked at the performance of the heart as they followed 31 patients, each undergoing a course of 60 hyperabric sessions with the goal of improving cognitive performance. Of these 31 patients, 39% were diagnosed with heart disease, 94% suffered from high blood pressure, and 42% had diabetes mellitus. Most importantly, all 31 patients were screened to be asymptomatic, and did not have any symptoms of heart disease (representing the majority of the public). Researchers docmumented their results by using pre and post imaging of the heart through ultrasound (echocardiogram). The results were extremely favourble following the addition of 60 hyperabric sessions; ejection fraction (EF) of the heart improved, Left ventricular end systolic volume decreased, Myocardial performance index [MPi] improved, Left ventricular [LV] global longitudinal strain increased, and apical rotation improved. This study gives hope for those individuals suffering from heart failure and systolic dsyfunction and who need to improve their cardiac performance view study
Researchers in this study followed and documented a 23 year old female, with an 11 year history of migraines, non-responsive to conventional drug therapies and who began a course of intensive hyperbaric therapy (40 sessions at 1.5 ATA in 8 weeks). It should be noted that previous to starting her hyperbaric therapy, her migraines were severe and would lead to significant loss of function.
By the 24th hyperbaric session, “she had only experienced a single migraine with aura but without debilitated pain. The patient stated that she never had a migraine with such little intensity prior to initiation of hyperbaric treatment and did not have to take any days off from work or school. Follow-up at the end of her 40-day treatment period revealed a highly-satisfied patient who had only experienced the single episode of a mild migraine during the entire course of treatment.” <view study>
Central sensitization is a condition of the nervous system that is associated with the development and maintenance of chronic pain. A new understanding of the role of hyperbaric oxygen therapy (HBOT) in central sensitization may be the key to effectively utilizing the benefits of this therapeutic intervention for pain management.
In this study, an experimental first degree burn injury was induced in 19 healthy male subjects followed by one single hyperbaric oxygen session (2.4 ATA, 100% oxygen, 90 min). The results from the hyperbaric session demonstrated a long lasting reduction in pain. In addition, the application of HBOT also demonstrated a protective effect through preconditioning. These results strongly support the effects on central sensitization through HBOT and may offer greater clinical applications for those suffering from chronic pain syndromes, particularly towards persistence post surgical pain and phantom limb pain, among other areas within clinical pain research. <View study — Journal of Pain Research 2019>
43 patients participated in a study for erectile dysfunction. The participants underwent a series of hyperbaric oxygen sessions for a total of 9 months. The collected data was very positive and the results of this study confirmed that hyperbaric oxygen therapy helped to improve erectile function. In addition, they measured both total and free serum testosterone levels and the data did not show any effect on testosterone levels. This would leave us to believe that the benefits of hyperbaric oxygen are not related to hormonal fluctuations occurring from this procedure, but instead other physiological benefits from the hyperbaric administration <view study>
Concussions, classified as mild traumatic brain injuries, are currently a major growing concern. The more we learn about this condion, the more we are able to see its devastating and long-lasting effects – even from just one concussion! Hyperbaric oxygen therapy is a very simple and safe procedure that has helped many patients recover from traumatic brain and head injuries. Recently more attention has been focused on hyperbaric oxygen therpay for concussion recovery, with overwhelmingly positive results. This study supports these reported benefits and demonstrated improvement in 21 of 25 neurocognitive test measures that were observed. Subjects received 40-82 one-hour treatments at 1.5 atmospheres absolute 100% oxygen <view study>
Deep chemical peels are commonly used by plastic surgeons to help with severely sun damaged skin, coarse wrinkles, scars, and even pre-cancerous growths. The procedure uses a chemical, Phenol, that removes the top layer of skin, causing smoother and younger looking skin to grow back. Phenol are the most aggressive type of skin peel, but can produce more dramatic results. The downside is that it involves longer recovery times. This is where hyperbaric oxygen comes into the picture. Hyperbaric therapy helps to speed up healing. In this study, patients undergoing phenol chemical peel (PCP) were divided into 2 groups. The first group had PCP only and the second group had 5 sessions of hyperbaric oxygen therapy following PCP. The Results: Hyperbaric oxygen therapy following PCP was associated with faster recovery as assessed by both patients and caregivers <view study>
Hyperbaric oxygen therapy is very well known for its positive effects in early bone healing and more importantly on its promotion of new bone growth. Now it is being more commonly used alongside dental procedures, including implants. For an implant to be successful, it ideally needs to have bone grow around it on all sides. This study was able to demonstrate that the addition of hyperbaric therapy improved bone growth following implantation. One of the key clinical benefits that was observed was that the healing time around the implants was significantly reduced. Overall, it may be a very good idea to utilize the regenerative benefits of hyperbaric oxygen therapy for patients undergoing dental surgery, particularly for those who are at greater risk for complications or failures <view study>
There have been numerous reports, medical studies, and clinical data to support the use of hyperbaric oxygen therapy (HBOT) for a vast number of liver diseases; namely, acute liver injury, nonalcoholic steatohepatitis, liver transplantation, fibrosis and cancer, especially for hepatic artery thrombosis. Review of the current literature tell us that HBOT can have a powerful effect on promoting liver regeneration. In terms of liver diseases, it seems that the key physiological benefits of HBOT are in its antioxidant and anti-inflammatory role, helping to provide protection for damaged liver tissue. The combination of extra protection (though antioxidant and anti-inflammatory support) and enhanced regeneration, make HBOT a potential valuable tool for many liver diseases.The authors of this study take a more in-depth analysis of HBOT’s role within these disease while also citing relevant studies <view study>
A prospective study analyzing 30 men who were diagnosed with ED for more than 6 months were treated with a course of 40 hyperbaric oxygen (HBOT) sessions. The results of this study showed remarkable benefits, even for those men who previously were unsuccessful in achieving erections! After HBOT, 63% of the men had none to mild erectile dysfunction. In addition, both penetration and maintenance of erections improved significantly — 24 of the 30 men (80%) reported improved erections. Furthermore, 7 participants who agreed to undergo penile perfusion MRI pre and post HBOT allowed the researchers to conclude: “HBOT reverses the basic common pathophysiology, atherosclerosis and decreased penile perfusion, responsible for most cases of ED” <view study>
Now published in the 2018 Journal of Diabetes, research confirms some of the recently noted benefits of mild hyperbaric oxygen (m-HBOT) therapy for diabetics. Specifically, in lowering fasting and non-fasting glucose, HbA1c, and triglyceride levels; all of which are important markers leading to advanced disease states associated with this diabetes. Researchers also focused on skeletal muscle activity and fibers, and found that m-HBOT was able to help the muscle’s natural ability to use oxygen (which is typically compromised in diabetics). By helping to sensitize sugar metabolism and oxygen use within the skeletal muscles, m-HBOT can provide a significant benefit for people with diabetes. It should be noted however, that this protocol provided rats with m-HBOT daily (3 hours per day) for 22 consecutive weeks (about 5 months). <view study>